Zobrazeno 1 - 10
of 55
pro vyhledávání: '"R H, Herzig"'
Autor:
A. Bashey, Patrick J. Stiff, R. P. Gale, Mei-Jie Zhang, G. L. Phillips, John R. Wingard, J. Gibson, A. D. Rubin, B. J. Bolwell, E. Montserrat, B. Yanes, R. H. Herzig, J. W. Fay, James O. Armitage, D. H. Vesole, W. Hiddemann, Mary M. Horowitz, L. J. Burns, A. Keating, I. Bence-Bruckler, S. Goldstein, K. Van Besien, Sergio Giralt, C. O. Freytes, D. P. Schenkein, Julie M. Vose, Hillard M. Lazarus, A. Miller, R. Martino, G. Milone, P. A. Rowlings, S. Pavlovsky, Philip L. McCarthy, A A Pecora
Publikováno v:
Journal of Clinical Oncology. 19:406-413
PURPOSE: To evaluate the results of high-dose chemotherapy and autologous hematopoietic stem-cell transplantation (autotransplants) in patients with diffuse aggressive non-Hodgkin’s lymphoma (NHL) who never achieve a complete remission with convent
Autor:
Brian J. Bolwell, Cesar O. Freytes, R. H. Herzig, S. N. Wolff, Don A. Stevens, L. Pineiro, Solveig G. Ericson, Joseph P. Lynch, Joseph W. Fay, Richard S. Stein, F. LeMaistre, Stacey Goodman, Stephen Dummer, John P. Greer, Robert H. Collins, Brad Pohlman
Publikováno v:
Bone Marrow Transplantation. 25:853-859
Systemic fungal infections are a major problem in bone marrow transplant recipients who have prolonged neutropenia or who receive high-dose corticosteroids. Prophylaxis with Fluconazole or low-dose amphotericin B reduces, but does not eliminate these
Autor:
J. M. Vose, S. Pavlovsky, James A. Russell, R. H. Herzig, D. D. Hurd, John P. Klein, Samuel M. Silver, F. B. Peterson, Robert Peter Gale, Philip A. Rowlings, Mary M. Horowitz, M. M. Bortin, S. Jagannath, Richard E. Champlin, Kathleen A. Sobocinski, James O. Armitage, J. L. Gajewski, G. L. Phillips, Hillard M. Lazarus, Philip L. McCarthy, P. H. Wiernik
Publikováno v:
Journal of Clinical Oncology. 14:572-578
PURPOSE To determine the outcome of HLA-identical sibling bone marrow transplants in advanced Hodgkin's disease. PATIENTS AND METHODS We reviewed the data on 100 consecutive patients with Hodgkin's disease who received HLA-identical sibling bone marr
Autor:
K Atkinson, Karel A. Dicke, Alberto M. Marmont, R. H. Herzig, John M. Goldman, Richard Szydlo, Robert Peter Gale, Mary M. Horowitz, Eliane Gluckman, Robert C. Ash
Publikováno v:
Blood. 82:2235-2238
We analyzed the outcome of 450 HLA-identical sibling bone marrow transplants for chronic myelogenous leukemia (CML) in chronic phase performed between 1985 and 1990 and reported to the International Bone Marrow Transplant Registry (IBMTR). All patien
Autor:
R. H. Herzig, John M. Goldman, AJ Barrett, Robert Peter Gale, Mary M. Horowitz, K Atkinson, Bruno Speck, F E Zwaan, P J Henslee-Downey, Robert C. Ash
Publikováno v:
Blood. 79:3067-3070
Philadelphia chromosome (Ph1)-positive acute lymphoblastic leukemia (ALL) has a poor prognosis when treated with conventional chemotherapy. We analyzed the outcome of 67 HLA-identical sibling bone marrow transplants (BMTs) for Ph1-positive ALL report
Autor:
A Gratwohl, H. G. Prentice, Robert Peter Gale, Mary M. Horowitz, Donna Przepiorka, O Ringden, R. H. Herzig, M. M. Bortin, A. A. Rimm, Richard E. Champlin
Publikováno v:
Blood. 79:2771-2774
There is substantial evidence that the volume of medical procedures in a hospital has an inverse relationship with mortality. We analyzed data for 1313 recipients of HLA-identical sibling bone marrow transplants for early leukemia (acute leukemia in
Autor:
G L, Phillips, J W, Fay, R H, Herzig, H M, Lazarus, S N, Wolff, H S, Lin, D C, Shina, G P, Glasgow, R C, Griffith, C W, Lamb
Publikováno v:
Blood. 75:831-838
Intensive chemoradiotherapy, with or without additional local radiotherapy, and unpurged autologous marrow transplantation was given to 68 patients with progressive non-Hodgkin's lymphoma. Responses were attained in 44 patients (65%, 95% confidence i
Autor:
L, Qiu, R H, Herzig
Publikováno v:
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi. 21(8)
To investigate the potential possibility that to expanse ex vivo umbilical cord blood (UCB) cells to an amount sufficient adults transplantation.Purified CD(34)(+) UCB cells from 10 fresh UCB samples were cultured for 7 days in IMDM mediums containin
Autor:
R E, Champlin, J R, Passweg, M J, Zhang, P A, Rowlings, C J, Pelz, K A, Atkinson, A J, Barrett, J Y, Cahn, W R, Drobyski, R P, Gale, J M, Goldman, A, Gratwohl, E C, Gordon-Smith, P J, Henslee-Downey, R H, Herzig, J P, Klein, A M, Marmont, R J, O'Reilly, O, Ringdén, S, Slavin, K A, Sobocinski, B, Speck, R S, Weiner, M M, Horowitz
Publikováno v:
Blood. 95(12)
T-cell depletion of donor marrow decreases graft-versus-host disease resulting from transplants from unrelated and human leukocyte antigen (HLA)-mismatched related donors. However, there are diverse strategies for T-cell-depleted transplantation, and
Autor:
S, Giralt, R, Szydlo, J M, Goldman, J, Veum-Stone, J C, Biggs, R H, Herzig, J P, Klein, P B, McGlave, G, Schiller, R P, Gale, P A, Rowlings, M M, Horowitz
Publikováno v:
Blood. 95(2)
Allogeneic bone marrow transplantation (BMT) is the only curative therapy for chronic myelogenous leukemia (CML), though several studies indicate that prolonged survival can result from interferon-alpha (IFN-alpha) treatment. IFN-alpha is now often u